retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity Retatrutide: Triple-Agonist for and Metabolic Health Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30


























